Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
2
×
balderton capital
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe blog main
europe top stories
fda
fundings & exits
indiana blog main
indiana top stories
life sciences
mytomorrows
national blog main
new york blog main
new york top stories
slgt2 inhibitor
sofinnova partners
startups
tc
type 1 diabetes
type 2 diabetes
What
approval
2
×
patients
2
×
access
amid
bid
boehringer
clinical
debate
development
diabetes
disrupt
drug
drugs
dutch
eli
expand
fallen
fda
funding
ingelheim
lengthy
lilly
marketed
medical
medicine’s
million
mytomorrows
needs
new
process
raised
raises
read
regulatory
rejects
right
short
stage
startup
treatments
Language
unset
Current search:
approval
×
patients
×
europe
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs
